AIF1 (allograft inflammatory factor 1), FCGR3, and HSPA1A [shock protein family A (Hsp70) member 1A] were finally identified as novel and valuable targets for psoriasis treatment, broadening new possible orientations of drug development for psoriasis. The gene discussed is HSPA1A; the disease is psoriasis.